EN HU

Kissné Bogáti Réka

Kissné Bogáti Réka

Publication list

2025
1.
Kissné Bogáti, R., Baráth, B., Pituk, D., Orbán-Kálmándi, R. A., Szűcs, P., Hegyi, Z., Bereczky, Z., Bagoly, Z., Katona, É.: Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure.
Biomolecules. 15 (8), 1-16, (article identifier: 1127), 2025.
Journal metrics:
Q1 Biochemistry (2024)
Q2 Molecular Biology (2024)
2024
2.
Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Int. J. Mol. Sci. 25 (5), 1-19, (article identifier: 2893), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
3.
Pituk, D., Balogh, L., Horváth, E., Hegyi, Z., Baráth, B., Kissné Bogáti, R., Szűcs, P., Papp, Z., Katona, É., Bereczky, Z.: Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution.
Int. J. Mol. Sci. 25 (21), 1-19, (article identifier: 11746), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2022
4.
Kissné Bogáti, R., Katona, É., Shemirani, A. H., Balogh, E., Bárdos, H., Jeney, V., Muszbek, L.: The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells.
Int. J. Mol. Sci. 23 (10), 1-15, (article identifier: 5845), 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2021
5.
Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z. A., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203, 110-116, 2021.
Journal metrics:
Q1 Hematology
6.
Bagoly, Z., Baráth, B., Orbán-Kálmándi, R. A., Szegedi, I., Kissné Bogáti, R., Sarkady, F., Csiba, L., Katona, É.: Incorporation of [alfa]2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Biomolecules. 11 (3), 1-13, (article identifier: 347), 2021.
Journal metrics:
Q2 Biochemistry
Q2 Molecular Biology
7.
Gindele, R., Pénzes-Daku, K., Balogh, G., Kállai, J., Kissné Bogáti, R., Bécsi, B., Erdődi, F., Katona, É., Bereczky, Z.: Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.
Biomolecules. 11 (4), 1-18, (article identifier: 544), 2021.
Journal metrics:
Q2 Biochemistry
Q2 Molecular Biology
2018
8.
Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z. A., Bereczky, Z.: ALPHA-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism in Patients with Venous Thromboembolism.
Proceedings. 2 (9), 102-103, 2018.
9.
Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z. A., Bereczky, Z.: The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism.
Res Pract Thromb Haemost. 2, 324-324, 2018.
2015
10.
Korponay-Szabó, I., Kerekes-Tóth, B., Gyimesi, J., Bartáné Tóth, B., Kissné Bogáti, R., Király, R., Caja, S., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L.: Search for gluten non-dependent prospective biomarkers for in vitro diagnostic use: 16th International Coeliac Disease Symposium 21-24 June 2015, Prague.
2013
11.
Tóth, B., Kissné Bogáti, R., Király, R., Simon-Vecsei, Z., Caja, S., Bartáné Tóth, B., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L., Korponay-Szabó, I.: Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2.
JPGN. 56 (Suppl_2), 200, 2013.
12.
Tóth, B., Kissné Bogáti, R., Király, R., Simon-Vecsei, Z., Caja, S., Bartáné Tóth, B., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L., Korponay-Szabó, I.: Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2: 46th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
DEENK University of Debrecen
© 2012 University of Debrecen